The tumor-specific CD4+ and CD8+ T cells are directed to the tumor site, where cytotoxic T lymphocytes destroy tumor cells, whose immunogenicities have been enhanced by exposure to locally produced IFN-γ. The gene discussed is IFNG; the disease is neoplasm.